Nucleoside Reverse Transcriptase Inhibitors

AIDSmeds.com - Nucleoside/Nucleotide Reverse Transcriptase

NRTIs, sometimes called "nucleoside analogues" or "nukes," contain faulty versions of the building blocks (nucleotides) used by reverse transcriptase to convert RNA to DNA. When reverse transcriptase uses these faulty building blocks, ... * efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI)

www.aidsmeds.com/NRTIs.htm

ChemGenes Corporation
Experience Nucleic Acid Expertise Amidites & Supports-Oligosynthesis
www.chemgenes.com

SMART cDNA Synthesis
Sensitive method for cDNA synthesis from small and dilute samples
www.clontech.com

Inhibitors
Buy your Inhibitors from us. Commitment to quality & value.
BostonBiochem.com/UbInhibitors

Actinomycine-D
Fisher Scientific offers a complete line of LS Research Products
www.Fishersci.com

Antiretroviral drug - Wikipedia, the free encyclopedia

Antiretroviral drugs are medications for the treatment of infection by retroviruses, primarily HIV. When several such drugs, typically three or four, are taken in combination, the approach is known a...
en.wikipedia.org/wiki/Antiretroviral_drug

Reverse transcriptase inhibitor - Wikipedia, the free encyclopedia

Reverse transcriptase inhibitors (RTIs) are a class of antiretroviral drug used to treat HIV infection, tumors, and cancer . RTIs inhibit activity of reverse transcriptase, a viral DNA polymerase enz...
en.wikipedia.org/wiki/Reverse_transcriptase_inhibitor

Adherence-resistance relationships for protease and non-nucleoside

OBJECTIVE: To compare the prevalence of resistance by adherence level in patients treated with non-nucleoside reverse transcriptase inhibitors (NNRTI) or protease inhibitors (PI). ... Reverse Transcriptase Inhibitors [therapeutic use]

www.medscape.com/medline/abstract/16511415

Non-Nucleoside Reverse Transcriptase Inhibitors in the Treatment of

This CME activity "Non-Nucleoside Reverse Transcriptase Inhibitors in the Treatment of HIV: Focus on Efficacy" was originally offered as a monograph certified for CME. ... Non-Nucleoside Reverse Transcriptase Inhibitors in the Treatment of HIV: Focus on Efficacy by Joel E. Gallant, MD, MPH; Kathleen E. Squires,

www.medscape.com/viewprogram/2853

HIV Medications - Nucleoside Reverse Transcriptase Inhibitors - HIV

Nucleoside reverse transcriptase inhibitors (NRTIs) are a class of HIV medications. Like all HIV medications, nucleoside reverse transcriptase inhibitors work on a specific step in the HIV life cycle, interrupting HIV replication and in turn the damage HIV causes to the immune system. ... The HIV life cycle includes many steps,

aids.about.com/od/hivmedicationfactsheets/a/nrti.htm

Non-Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors is the third class of HIV medications. Learn what you need to know here. ... Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

aids.about.com/od/hivmedicationfactsheets/a/nnrti.htm

904] ANTIFUNGAL ACTIVITY OF NUCLEOSIDE ANALOGUES AND NON-NUCLEOSIDE

Nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), susceptibility, Candida spp., Cryptococcus neoformans ... ; [TITLE:] ANTIFUNGAL ACTIVITY OF NUCLEOSIDE ANALOGUES AND NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS; [AUTHOR(S):]

www.aegis.com/conferences/IASHIVPT/2003/904.html

All About AIDS: Non-Nucleoside Reverse Transcriptase Inhibitors

The second type of drug to be developed to fight HIV were non-nucleoside reverse transcriptase inhibitors, abbreviated NNRTI, and approved in 1996. Like nucleoside RT inhibitors, NNRTI’s stop the conversion of HIV RNA to DNA prior to integration into the host cell DNA.

library.thinkquest.org/03oct/01335/en/txt/nnrti.html

AEGiS-14IAC: Triple antiretroviral therapy containing non-nucleoside

BACKGROUND: Few data on the use of triple antiretroviral therapy containing non-nucleoside reverse transcriptase inhibitors (NNRTIs) in deeply immunossuppressed antiretroviral naïve HIV-1-infected patients are available.

www.aegis.com/conferences/iac/2002/TuPeB4457.html